Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-8 of 8 for your search:
Drug:
recombinant interleukin-1-beta
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase II Study of 131I-Labeled MOAB CC49 plus IL-1B in Patients with Colorectal Cancer (Summary Last Modified 06/92)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
UAC-2110
, NCI-T91-0203C, T91-0203
2.
Phase II Study of IL-1B in Patients with Metastatic Renal Cell Carcinoma (Summary Last Modified 08/92)
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
WSU-C-98591
, NCI-T91-0272D, T91-0272
3.
Phase I Study of the Pharmacokinetics, Tolerance to, and Hematologic Effect of Intravenous Interleukin-1-Beta in Adults Receiving 5-Fluorouracil for Advanced Colorectal Cancer (Summary Last Modified 03/89)
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
over 18
Sponsor:
Protocol IDs:
MSKCC-88119
, NCI-V89-0008
4.
Phase I Study of IL-1B/CBDCA/VP-16 in Patients with Metastatic Cancer (Summary Last Modified 08/92)
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
over 18
Sponsor:
NCI
Protocol IDs:
SWOG-8940
5.
Phase IB Study of Interleukin-1-beta in Patients with Advanced Solid Tumors (Summary Last Modified 06/97)
Phase:
Phase I
Type:
Supportive care, Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
BRMP-8811A
, NCI-90-C-62A, NCI-T89-0185N, T89-0185
6.
Phase I Study of Concomitant IL-1B and G-CSF Followed by Autologous Stem Cell Rescue from Myeloablative Chemotherapy with ICE (IFF/CBDCA/VP-16) in Patients with Refractory Intermediate-Grade non-Hodgkin's Lymphoma or Hodgkin's Disease (Summary Last Modified 05/92)
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
18 to physiologic 64
Sponsor:
NCI
Protocol IDs:
BRMP-9101D
, NCI-91-C-99D, NCI-T91-0021N, T91-0021
7.
Phase I Study of IL-1B/IL-2 in Patients with Metastatic Kidney Cancer, Colorectal Cancer, or Malignant Melanoma (Summary Last Modified 02/92)
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
Protocol IDs:
OSU-91HO154
, NCI-B91-0021, B91-0021
8.
Phase I Pilot Study of IL-1B with and without CBDCA/CTX in Patients with Advanced Cancer (Summary Last Modified 01/94)
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MAYO-900302
, NCI-T91-0157C, T91-0157
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute